TABLE 3.
Treatments and outcomes of patients infected with the Omicron variant or Delta variant.
| Omicron variant (n = 384) |
Delta variant (n = 103) |
P | |
| Admission to intensive care unit | 0 | 10 (10%) | 0 |
| Acute kidney injury | 1 (0.3%) | 0 | 1 |
| Anemia | 1 (0.3%) | 0 | 1 |
| Secondary infection | 1 (0.3%) | 0 | 1 |
| Shock | 0 | 1 (1%) | 0.211 |
| Treatment | |||
| TCM treatment | 381 (99%) | 93 (90%) | 0 |
| Immunotherapy | 143 (37%) | 35 (34%) | 0.542 |
| Antiviral treatment | 8 (2%) | 16 (16%) | 0 |
| Antibiotics | 11 (3%) | 16 (16%) | 0 |
| Interferon inhalation | 22 (6%) | 13 (13%) | 0.016 |
| Heparin | 33 (9%) | 26 (25%) | 0 |
| Chloroquine phosphate | 0 | 3 (3%) | 0.008 |
| Glucocorticoid treatment | 0 | 0 | ⋅⋅ |
| Continuous renal-replacement therapy | 0 | 0 | ⋅⋅ |
| Oxygen support | |||
| Nasal cannula | 4 (1%) | 17 (17%) | 0 |
| Non-invasive ventilation or high-flow nasal cannula | 0 | 2 (2%) | 0.044 |
| Invasive mechanical ventilation | 0 | 2 (2%) | 0.044 |
| Invasive mechanical ventilation and ECMO | 0 | 2 (2%) | 0.044 |
| Prognosis | |||
| Hospitalization | 0 | 0 | ⋅⋅ |
| Discharge | 384 (100%) | 103 (100%) | ⋅⋅ |
| Death | 0 | 0 | ⋅⋅ |
| Hospital stay, days | 19 (15–25) | 26 (18–46) | 0 |
| Disease duration, days | 22 (17–28) (n = 362) | 28 (21–47) (n = 101) | 0 |
Percentages do not total 100% owing to missing data.
Data are median (IQR), n (%), or n/N (%), where N is the total number of patients with available data.
P comparing Omicron variant and Delta variant are from χ2, Fisher’s exact test, or Mann–Whitney U test.